Manufacture and storage of two master cell bank batches of menstrual blood-derived mesenchymal cells

Summary

The Bellvitge Biomedical Research Institute Foundation is procuring the GMP-compliant manufacture, quality control and storage of two master cell bank batches of mesenchymal cells derived from menstrual blood. Approximately 25% of the cryovials from each batch will be sent to IDIBELL for preclinical studies, while the remainder will be stored for up to five years. The procurement is a single contract, not divided into lots, with a budget of EUR 38,300 excluding VAT.